GlassScriptPhysician profile
Harley D Miller
NPI 1780628727
$453.96
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.63 · 2020: $14.02 · 2021: $154 · 2022: $39.15 · 2023: $65.57 · 2024: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $119.13 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $60.66 | 2021 | |
| Abbvie INC. | $45.98 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $44.09 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.84 | 2023 | |
| Gilead Sciences, INC. | $30.79 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $30.54 | 2022-2024 | Lokelma |
| Dexcom, INC. | $22.55 | 2024 | Dexcom G6 Transmitter |
| Nevro Corp. | $20.48 | 2021 | |
| Glaxosmithkline, LLC. | $16.85 | 2024 | Arexvy, Trelegy Ellipta |
| Boston Scientific Corporation | $16.03 | 2023 | Watchman |
| Horizon Therapeutics Plc | $14.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harley Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.